hotspot -WSS

hotspot

author：entertainment 2025-10-02 12:32:10 - browse：89348

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

WSS

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Stanford updates investigation of president’s past research

TikTok cracks down on users posting about weight loss drugs

Allen Institute goes after foundational questions, CEO Costa says

Celebrate National Dole Whip Day for 3 days this week at Disney

Allen Institute goes after foundational questions, CEO Costa says

focus

hotspot

entertainment

Apple is now the first public company to be valued at $3 trillion

Ascension's ugly legal battle over care for poor patients in Texas

Peter Hotez and the public health issue of online harassment

In shift, Texas to cover initial consult for Afghan baby's gene therapy

What does generative AI mean for health care? We asked experts

Seattle police shoot person suspected in downtown stabbing

Dobbs anniversary: the lost opportunity of abortion as health care

In shift, Texas to cover initial consult for Afghan baby's gene therapy

In age of alternative facts, a scholarly course on calling out crap

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

hotspot

New warning issued for rebooking air travel after delays, cancellations

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Researchers separate signal from noise in heart wearable data

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Allen Institute goes after foundational questions, CEO Costa says

At JPM 2024, hospital systems pitch financial strength to investors

knowledge

focus

focus

knowledge